Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

With METROPOLIS's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 1.403000
forwardPE 35.369854
debtToEquity 15.212000
earningsGrowth 0.730000
revenueGrowth 0.230000
grossMargins 0.802830
operatingMargins 0.163480
trailingEps 9.190000
forwardEps 15.158390

With a current ratio of 1.403, METROPOLIS has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that METROPOLIS is in a strong position to meet its immediate financial obligations without difficulty.
Metropolis Healthcare Limited's low Debt-to-Equity ratio reflects that the company isn't heavily reliant on debt, reducing financial risk. This conservative approach suggests Metropolis Healthcare Limited maintains a stable financial foundation, with greater flexibility to manage future growth or challenges without over-leverage concerns.
METROPOLIS's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that METROPOLIS is expected to continue expanding its business and boosting its financial performance in the coming periods.
METROPOLIS's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that METROPOLIS is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

The price of METROPOLIS has regularly been close to the lower end of projections, suggesting that it might be struggling to meet market expectations. This trend raises questions about the company's future performance.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


A recent buy bias from analysts toward METROPOLIS indicates strong confidence in the stock's future performance. This could encourage investors to park their money in METROPOLIS, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.